25 XP   0   0   10

argenx NV ADR
Buy, Hold or Sell?

Let's analyse Argenx together

PenkeI guess you are interested in argenx NV ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of argenx NV ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about argenx NV ADR

I send you an email if I find something interesting about argenx NV ADR.

Quick analysis of Argenx (30 sec.)










What can you expect buying and holding a share of Argenx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$69.10
Expected worth in 1 year
$155.69
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$86.59
Return On Investment
24.2%

For what price can you sell your share?

Current Price per Share
$358.41
Expected price per share
$327.73 - $416.91
How sure are you?
50%

1. Valuation of Argenx (5 min.)




Live pricePrice per Share (EOD)

$358.41

Intrinsic Value Per Share

$-139.40 - $-45.70

Total Value Per Share

$-70.31 - $23.39

2. Growth of Argenx (5 min.)




Is Argenx growing?

Current yearPrevious yearGrowGrow %
How rich?$4b$2.8b$1.2b31.3%

How much money is Argenx making?

Current yearPrevious yearGrowGrow %
Making money-$295m-$709.5m$414.5m140.5%
Net Profit Margin-24.1%-172.8%--

How much money comes from the company's main activities?

3. Financial Health of Argenx (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#19 / 1016

Most Revenue
#15 / 1016

Most Profit
#1013 / 1016

Most Efficient
#506 / 1016

What can you expect buying and holding a share of Argenx? (5 min.)

Welcome investor! Argenx's management wants to use your money to grow the business. In return you get a share of Argenx.

What can you expect buying and holding a share of Argenx?

First you should know what it really means to hold a share of Argenx. And how you can make/lose money.

Speculation

The Price per Share of Argenx is $358.41. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Argenx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Argenx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $69.10. Based on the TTM, the Book Value Change Per Share is $21.65 per quarter. Based on the YOY, the Book Value Change Per Share is $4.71 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Argenx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-4.98-1.4%-4.98-1.4%-11.97-3.3%-7.10-2.0%-3.79-1.1%
Usd Book Value Change Per Share21.656.0%21.656.0%4.711.3%11.743.3%6.861.9%
Usd Dividend Per Share0.000.0%0.000.0%0.090.0%0.020.0%0.010.0%
Usd Total Gains Per Share21.656.0%21.656.0%4.801.3%11.763.3%6.871.9%
Usd Price Per Share380.43-380.43-378.83-312.81-172.33-
Price to Earnings Ratio-76.46--76.46--31.66--50.07--46.92-
Price-to-Total Gains Ratio17.57-17.57-78.84-34.49-30.20-
Price to Book Ratio5.51-5.51-7.98-8.03-5.85-
Price-to-Total Gains Ratio17.57-17.57-78.84-34.49-30.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share358.41
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share21.6511.74
Usd Total Gains Per Share21.6511.76
Gains per Quarter (2 shares)43.3023.52
Gains per Year (2 shares)173.1994.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1017316309484
203463360188178
305205090282272
406936821376366
508668551470460
60103910281564554
70121212011658648
80138613741751742
90155915471845836
100173217201939930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.02.00.084.6%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.012.07.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.02.00.084.6%

Fundamentals of Argenx

About argenx NV ADR

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

Fundamental data was last updated by Penke on 2024-04-09 20:23:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of argenx NV ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Argenx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Argenx to the Biotechnology industry mean.
  • A Net Profit Margin of -24.1% means that $-0.24 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of argenx NV ADR:

  • The MRQ is -24.1%. The company is making a huge loss. -2
  • The TTM is -24.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM-24.1%0.0%
TTM-24.1%YOY-172.8%+148.7%
TTM-24.1%5Y-392.9%+368.8%
5Y-392.9%10Y-299.5%-93.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.1%-197.2%+173.1%
TTM-24.1%-210.4%+186.3%
YOY-172.8%-279.3%+106.5%
5Y-392.9%-436.8%+43.9%
10Y-299.5%-599.3%+299.8%
1.1.2. Return on Assets

Shows how efficient Argenx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Argenx to the Biotechnology industry mean.
  • -6.5% Return on Assets means that Argenx generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of argenx NV ADR:

  • The MRQ is -6.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-6.5%0.0%
TTM-6.5%YOY-22.6%+16.1%
TTM-6.5%5Y-16.7%+10.2%
5Y-16.7%10Y-17.4%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.5%-13.6%+7.1%
TTM-6.5%-12.9%+6.4%
YOY-22.6%-11.9%-10.7%
5Y-16.7%-14.2%-2.5%
10Y-17.4%-16.2%-1.2%
1.1.3. Return on Equity

Shows how efficient Argenx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Argenx to the Biotechnology industry mean.
  • -7.2% Return on Equity means Argenx generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of argenx NV ADR:

  • The MRQ is -7.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-7.2%0.0%
TTM-7.2%YOY-25.2%+18.0%
TTM-7.2%5Y-20.6%+13.4%
5Y-20.6%10Y-21.9%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-17.0%+9.8%
TTM-7.2%-16.1%+8.9%
YOY-25.2%-15.4%-9.8%
5Y-20.6%-20.0%-0.6%
10Y-21.9%-21.1%-0.8%

1.2. Operating Efficiency of argenx NV ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Argenx is operating .

  • Measures how much profit Argenx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Argenx to the Biotechnology industry mean.
  • An Operating Margin of -27.1% means the company generated $-0.27  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of argenx NV ADR:

  • The MRQ is -27.1%. The company is operating very inefficient. -2
  • The TTM is -27.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-27.1%TTM-27.1%0.0%
TTM-27.1%YOY-175.2%+148.1%
TTM-27.1%5Y-335.0%+308.0%
5Y-335.0%10Y-275.8%-59.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.1%-286.1%+259.0%
TTM-27.1%-224.4%+197.3%
YOY-175.2%-288.4%+113.2%
5Y-335.0%-475.2%+140.2%
10Y-275.8%-624.7%+348.9%
1.2.2. Operating Ratio

Measures how efficient Argenx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are $1.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of argenx NV ADR:

  • The MRQ is 1.343. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.343. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.343TTM1.3430.000
TTM1.343YOY2.752-1.409
TTM1.3435Y6.446-5.103
5Y6.44610Y7.284-0.838
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3432.997-1.654
TTM1.3433.247-1.904
YOY2.7523.766-1.014
5Y6.4465.675+0.771
10Y7.2847.857-0.573

1.3. Liquidity of argenx NV ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Argenx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.75 means the company has $9.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of argenx NV ADR:

  • The MRQ is 9.749. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.749. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.749TTM9.7490.000
TTM9.749YOY9.178+0.571
TTM9.7495Y8.443+1.306
5Y8.44310Y8.493-0.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7493.930+5.819
TTM9.7494.251+5.498
YOY9.1785.436+3.742
5Y8.4436.045+2.398
10Y8.4936.363+2.130
1.3.2. Quick Ratio

Measures if Argenx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Argenx to the Biotechnology industry mean.
  • A Quick Ratio of 11.37 means the company can pay off $11.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of argenx NV ADR:

  • The MRQ is 11.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.372TTM11.3720.000
TTM11.372YOY12.775-1.404
TTM11.3725Y11.728-0.356
5Y11.72810Y11.831-0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3723.629+7.743
TTM11.3724.065+7.307
YOY12.7755.397+7.378
5Y11.7285.993+5.735
10Y11.8316.277+5.554

1.4. Solvency of argenx NV ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Argenx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Argenx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Argenx assets are financed with 9.8% credit (debt) and the remaining percentage (100% - 9.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of argenx NV ADR:

  • The MRQ is 0.098. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.098. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.098TTM0.0980.000
TTM0.098YOY0.102-0.004
TTM0.0985Y0.169-0.071
5Y0.16910Y0.172-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0980.332-0.234
TTM0.0980.334-0.236
YOY0.1020.268-0.166
5Y0.1690.366-0.197
10Y0.1720.390-0.218
1.4.2. Debt to Equity Ratio

Measures if Argenx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Argenx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.9% means that company has $0.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of argenx NV ADR:

  • The MRQ is 0.109. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.109. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.109TTM0.1090.000
TTM0.109YOY0.114-0.005
TTM0.1095Y0.215-0.106
5Y0.21510Y0.229-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1090.381-0.272
TTM0.1090.390-0.281
YOY0.1140.334-0.220
5Y0.2150.434-0.219
10Y0.2290.466-0.237

2. Market Valuation of argenx NV ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Argenx generates.

  • Above 15 is considered overpriced but always compare Argenx to the Biotechnology industry mean.
  • A PE ratio of -76.46 means the investor is paying $-76.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of argenx NV ADR:

  • The EOD is -72.036. Based on the earnings, the company is expensive. -2
  • The MRQ is -76.462. Based on the earnings, the company is expensive. -2
  • The TTM is -76.462. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-72.036MRQ-76.462+4.426
MRQ-76.462TTM-76.4620.000
TTM-76.462YOY-31.660-44.802
TTM-76.4625Y-50.075-26.387
5Y-50.07510Y-46.923-3.152
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-72.036-2.315-69.721
MRQ-76.462-2.560-73.902
TTM-76.462-2.664-73.798
YOY-31.660-4.122-27.538
5Y-50.075-6.258-43.817
10Y-46.923-6.108-40.815
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of argenx NV ADR:

  • The EOD is -45.793. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -48.607. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -48.607. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-45.793MRQ-48.607+2.813
MRQ-48.607TTM-48.6070.000
TTM-48.607YOY-23.241-25.366
TTM-48.6075Y-9.850-38.757
5Y-9.85010Y-22.518+12.669
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-45.793-3.067-42.726
MRQ-48.607-3.251-45.356
TTM-48.607-3.545-45.062
YOY-23.241-5.595-17.646
5Y-9.850-8.315-1.535
10Y-22.518-8.708-13.810
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Argenx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.51 means the investor is paying $5.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of argenx NV ADR:

  • The EOD is 5.187. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.506. Based on the equity, the company is overpriced. -1
  • The TTM is 5.506. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.187MRQ5.506-0.319
MRQ5.506TTM5.5060.000
TTM5.506YOY7.984-2.478
TTM5.5065Y8.033-2.527
5Y8.03310Y5.846+2.187
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.1871.905+3.282
MRQ5.5062.111+3.395
TTM5.5062.095+3.411
YOY7.9842.836+5.148
5Y8.0333.443+4.590
10Y5.8463.794+2.052
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of argenx NV ADR.

3.1. Institutions holding argenx NV ADR

Institutions are holding 55.871% of the shares of argenx NV ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc6.42870.11143812372-1152601-23.2146
2023-12-31T. Rowe Price Associates, Inc.6.19510.18783673855143400.3919
2023-12-31Artisan Partners Limited Partnership5.3531.8594317447734617812.2398
2023-12-31Capital World Investors3.30710.1327196120253018137.0491
2023-12-31HHG PLC2.99610.4031177675930562120.7745
2023-12-31venBio Select Advisor LLC2.08186.4873123456723456723.4567
2023-12-31T. Rowe Price Investment Management,Inc.1.99340.2924118212121576522.3277
2023-12-31BlackRock Inc1.67280.0096992037-161-0.0162
2023-12-31Bellevue Group AG1.46575.0582869208-42322-4.643
2023-12-31RTW INVESTMENTS, LLC1.12513.964866719516000031.5461
2023-12-31Morgan Stanley - Brokerage Accounts1.10090.02196528879797717.6564
2023-12-31Massachusetts Financial Services Company0.99770.0727591666100801.7332
2023-12-31Goldman Sachs Group Inc0.85110.0172504738351105228.5349
2023-12-31ClearBridge Advisors, LLC0.73660.1434367979243326.8417
2023-12-31Amvescap Plc.0.73560.039543623354461.2642
2023-09-30Citadel Advisors Llc0.73540.0464361237553520.9477
2023-12-31Paradigm Biocapital Advisors LP0.71267.526542257716113461.6326
2023-09-30Holocene Advisors, LP0.62760.8011372155138993.8796
2023-12-31Federated Hermes Inc0.60120.3367356507244167.3522
2023-12-31Millennium Management LLC0.58250.05693454316710924.112
Total 40.327.568223898907+1510702+6.3%

3.2. Funds holding argenx NV ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds Europacific Growth A1.89030.314112099100
2023-12-31Capital Group EuroPacific Growth Comp1.89030.314112099100
2023-12-31US Small-Cap Growth II Equity Comp1.81551.64971076626-3400-0.3148
2023-12-31T. Rowe Price New Horizons1.81551.65541076626-3400-0.3148
2023-09-30BB Biotech AG Ord1.449817.2939859775-5225-0.604
2024-02-29Fidelity Growth Compy Commingled Pl O1.42270.4087843707-1500-0.1775
2023-12-31T. Rowe Price Health Sciences1.21291.86719279107281.5141
2024-02-29Fidelity Growth Company Fund1.0750.40663748500
2023-12-31T. Rowe Price US Growth Stock Composite0.92780.4524550216-25241-4.3863
2023-12-31T. Rowe Price U.S. Growth Stock SMA0.92780.4434550216550140723868.4211
2023-12-31T. Rowe Price Growth Stock0.92780.4458550216-25241-4.3863
2023-12-31T. Rowe Price Mid-Cap Growth0.71580.533342450010960034.8047
2023-12-31T. Rowe Price US Mid-Cap Growth Equity0.71580.531642450010960034.8047
2023-12-31American Funds Capital World Gr&Inc A0.67240.1293987503987500
2023-12-31Capital Group World Growth & Inc Cmp0.67240.1293987503987500
2023-12-31Artisan U.S. Mid-Cap Growth0.64183.050738062478372.1023
2023-12-31Artisan Mid Cap Investor0.64183.053738062478372.1023
2024-03-28iShares Biotechnology ETF0.63481.9424376470-655-0.1737
2024-02-29Invesco Developing Markets A0.5990.603135519300
2023-12-31Invesco Emerging Markets Equity0.5990.596135519312155452.0264
Total 21.248235.812212600732+1650134+13.1%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of argenx NV ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--21.64921.6490%4.713+359%11.742+84%6.859+216%
Book Value Per Share--69.09569.0950%47.447+46%41.484+67%22.762+204%
Current Ratio--9.7499.7490%9.178+6%8.443+15%8.493+15%
Debt To Asset Ratio--0.0980.0980%0.102-4%0.169-42%0.172-43%
Debt To Equity Ratio--0.1090.1090%0.114-5%0.215-49%0.229-53%
Dividend Per Share----0%0.092-100%0.018-100%0.009-100%
Eps---4.975-4.9750%-11.966+140%-7.099+43%-3.794-24%
Free Cash Flow Per Share---7.827-7.8270%-16.300+108%-8.386+7%-4.393-44%
Free Cash Flow To Equity Per Share--14.71414.7140%-2.072+114%8.343+76%5.218+182%
Gross Profit Margin--1.6851.6850%1.003+68%1.180+43%1.093+54%
Intrinsic Value_10Y_max---45.705--------
Intrinsic Value_10Y_min---139.403--------
Intrinsic Value_1Y_max---4.443--------
Intrinsic Value_1Y_min---12.727--------
Intrinsic Value_3Y_max---13.454--------
Intrinsic Value_3Y_min---39.542--------
Intrinsic Value_5Y_max---22.591--------
Intrinsic Value_5Y_min---67.579--------
Market Cap21254501502.000-6%22560335946.00022560335946.0000%22465452426.000+0%18550439786.400+22%10219370219.400+121%
Net Profit Margin---0.241-0.2410%-1.728+618%-3.929+1533%-2.995+1145%
Operating Margin---0.271-0.2710%-1.752+547%-3.350+1137%-2.758+918%
Operating Ratio--1.3431.3430%2.752-51%6.446-79%7.284-82%
Pb Ratio5.187-6%5.5065.5060%7.984-31%8.033-31%5.846-6%
Pe Ratio-72.036+6%-76.462-76.4620%-31.660-59%-50.075-35%-46.923-39%
Price Per Share358.410-6%380.430380.4300%378.830+0%312.812+22%172.327+121%
Price To Free Cash Flow Ratio-45.793+6%-48.607-48.6070%-23.241-52%-9.850-80%-22.518-54%
Price To Total Gains Ratio16.556-6%17.57317.5730%78.842-78%34.488-49%30.203-42%
Quick Ratio--11.37211.3720%12.775-11%11.728-3%11.831-4%
Return On Assets---0.065-0.0650%-0.226+249%-0.167+156%-0.174+167%
Return On Equity---0.072-0.0720%-0.252+250%-0.206+186%-0.219+204%
Total Gains Per Share--21.64921.6490%4.805+351%11.760+84%6.868+215%
Usd Book Value--4097507000.0004097507000.0000%2813700000.000+46%2460112063.400+67%1349855354.913+204%
Usd Book Value Change Per Share--21.64921.6490%4.713+359%11.742+84%6.859+216%
Usd Book Value Per Share--69.09569.0950%47.447+46%41.484+67%22.762+204%
Usd Dividend Per Share----0%0.092-100%0.018-100%0.009-100%
Usd Eps---4.975-4.9750%-11.966+140%-7.099+43%-3.794-24%
Usd Free Cash Flow---464139000.000-464139000.0000%-966630000.000+108%-497297980.688+7%-260497232.076-44%
Usd Free Cash Flow Per Share---7.827-7.8270%-16.300+108%-8.386+7%-4.393-44%
Usd Free Cash Flow To Equity Per Share--14.71414.7140%-2.072+114%8.343+76%5.218+182%
Usd Market Cap21254501502.000-6%22560335946.00022560335946.0000%22465452426.000+0%18550439786.400+22%10219370219.400+121%
Usd Price Per Share358.410-6%380.430380.4300%378.830+0%312.812+22%172.327+121%
Usd Profit---295053000.000-295053000.0000%-709594000.000+140%-449202125.590+52%-240768598.459-18%
Usd Revenue--1226316000.0001226316000.0000%410746000.000+199%451461791.800+172%235310397.262+421%
Usd Total Gains Per Share--21.64921.6490%4.805+351%11.760+84%6.868+215%
 EOD+2 -6MRQTTM+0 -0YOY+31 -55Y+31 -510Y+25 -11

4.2. Fundamental Score

Let's check the fundamental score of argenx NV ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-72.036
Price to Book Ratio (EOD)Between0-15.187
Net Profit Margin (MRQ)Greater than0-0.241
Operating Margin (MRQ)Greater than0-0.271
Quick Ratio (MRQ)Greater than111.372
Current Ratio (MRQ)Greater than19.749
Debt to Asset Ratio (MRQ)Less than10.098
Debt to Equity Ratio (MRQ)Less than10.109
Return on Equity (MRQ)Greater than0.15-0.072
Return on Assets (MRQ)Greater than0.05-0.065
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of argenx NV ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.502
Ma 20Greater thanMa 50386.878
Ma 50Greater thanMa 100388.273
Ma 100Greater thanMa 200398.346
OpenGreater thanClose362.340
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,542,458
Total Liabilities444,951
Total Stockholder Equity4,097,507
 As reported
Total Liabilities 444,951
Total Stockholder Equity+ 4,097,507
Total Assets = 4,542,458

Assets

Total Assets4,542,458
Total Current Assets4,123,737
Long-term Assets418,721
Total Current Assets
Cash And Cash Equivalents 2,048,844
Short-term Investments 1,131,000
Net Receivables 499,271
Inventory 310,550
Other Current Assets 134,072
Total Current Assets  (as reported)4,123,737
Total Current Assets  (calculated)4,123,737
+/-0
Long-term Assets
Property Plant Equipment 22,676
Long Term Investments 47,155
Intangible Assets 125,228
Long-term Assets Other 126,451
Long-term Assets  (as reported)418,721
Long-term Assets  (calculated)321,510
+/- 97,211

Liabilities & Shareholders' Equity

Total Current Liabilities422,993
Long-term Liabilities21,958
Total Stockholder Equity4,097,507
Total Current Liabilities
Short-term Debt 4,646
Accounts payable 245,557
Other Current Liabilities 172,790
Total Current Liabilities  (as reported)422,993
Total Current Liabilities  (calculated)422,993
+/-0
Long-term Liabilities
Capital Lease Obligations 20,000
Long-term Liabilities  (as reported)21,958
Long-term Liabilities  (calculated)20,000
+/- 1,958
Total Stockholder Equity
Common Stock7,058
Retained Earnings -2,404,844
Accumulated Other Comprehensive Income 72,071
Other Stockholders Equity 6,423,222
Total Stockholder Equity (as reported)4,097,507
Total Stockholder Equity (calculated)4,097,507
+/-0
Other
Capital Stock7,058
Cash and Short Term Investments 3,179,844
Common Stock Shares Outstanding 57,169
Liabilities and Stockholders Equity 4,542,458
Net Debt -2,028,844
Net Invested Capital 4,097,507
Net Working Capital 3,700,744
Property Plant and Equipment Gross 45,351
Short Long Term Debt Total 20,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
12,261
31,941
22,930
34,540
71,149
50,250
111,241
444,979
661,700
1,605,586
2,284,873
2,850,274
3,134,261
4,542,458
4,542,4583,134,2612,850,2742,284,8731,605,586661,700444,979111,24150,25071,14934,54022,93031,94112,261
   > Total Current Assets 
11,892
31,569
22,479
33,731
69,771
48,255
107,056
440,056
654,819
1,538,242
2,061,782
2,542,971
2,774,197
4,123,737
4,123,7372,774,1972,542,9712,061,7821,538,242654,819440,056107,05648,25569,77133,73122,47931,56911,892
       Cash And Cash Equivalents 
10,501
30,515
20,406
31,373
39,131
38,828
94,545
228,984
321,482
371,093
1,219,631
1,334,676
800,740
2,048,844
2,048,844800,7401,334,6761,219,631371,093321,482228,98494,54538,82839,13131,37320,40630,51510,501
       Short-term Investments 
0
0
1,389
690
28,933
7,449
7,184
202,638
324,330
1,125,257
781,461
1,002,052
1,391,808
1,131,000
1,131,0001,391,8081,002,052781,4611,125,257324,330202,6387,1847,44928,9336901,38900
       Net Receivables 
1,386
986
569
1,519
1,593
1,483
2,243
3,599
3,646
31,786
7,458
38,221
277,275
499,271
499,271277,27538,2217,45831,7863,6463,5992,2431,4831,5931,5195699861,386
       Other Current Assets 
5
1
3
1
2
496
3,084
4,835
5,361
1,033,110
27,978
58,946
-1
134,072
134,072-158,94627,9781,033,1105,3614,8353,08449621315
   > Long-term Assets 
369
372
451
809
1,379
1,995
4,185
4,924
6,881
67,345
223,091
307,303
360,064
418,721
418,721360,064307,303223,09167,3456,8814,9244,1851,9951,379809451372369
       Property Plant Equipment 
328
356
231
166
202
271
806
811
943
9,148
11,677
15,843
16,235
22,676
22,67616,23515,84311,6779,148943811806271202166231356328
       Long Term Investments 
0
0
0
1
1
1
1
1
1
2,596
5,140
53,169
40,481
47,155
47,15540,48153,1695,1402,596111111000
       Intangible Assets 
41
16
0
0
9
8
18
16
64
44,987
167,778
171,684
174,901
125,228
125,228174,901171,684167,77844,98764161889001641
       Other Assets 
0
0
0
0
-1
0
3,195
0
0
0
30,340
119,775
128,448
0
0128,448119,77530,3400003,1950-10000
> Total Liabilities 
2,029
4,043
6,278
4,568
10,249
9,494
44,590
31,165
45,828
428,570
606,760
316,050
320,561
444,951
444,951320,561316,050606,760428,57045,82831,16544,5909,49410,2494,5686,2784,0432,029
   > Total Current Liabilities 
2,029
4,043
6,278
4,569
10,249
9,494
44,589
31,135
45,820
179,179
329,257
301,239
302,277
422,993
422,993302,277301,239329,257179,17945,82031,13544,5899,49410,2494,5696,2784,0432,029
       Short-term Debt 
0
2,193
2,238
0
0
0
0
0
0
2,211
3,484
3,509
3,417
4,646
4,6463,4173,5093,4842,2110000002,2382,1930
       Accounts payable 
1,690
363
1,850
1,241
2,005
2,062
4,612
18,337
6,871
95,552
206,804
208,850
188,721
245,557
245,557188,721208,850206,80495,5526,87118,3374,6122,0622,0051,2411,8503631,690
       Other Current Liabilities 
0
1,487
1,620
2,698
4,047
2,905
8,210
716
36,477
385
72,533
88,880
110,139
172,790
172,790110,13988,88072,53338536,4777168,2102,9054,0472,6981,6201,4870
   > Long-term Liabilities 
2,029
2,556
4,658
-1
6,202
6,589
1
30
8
249,391
277,503
14,811
18,284
21,958
21,95818,28414,811277,503249,39183016,5896,202-14,6582,5562,029
       Other Liabilities 
0
0
0
0
0
0
10,071
1,460
7
218,096
220,588
6,855
9,276
0
09,2766,855220,588218,09671,46010,071000000
> Total Stockholder Equity
10,232
27,898
16,652
29,972
60,900
40,756
66,651
413,815
615,872
1,177,016
1,678,113
2,534,224
2,813,700
4,097,507
4,097,5072,813,7002,534,2241,678,1131,177,016615,872413,81566,65140,75660,90029,97216,65227,89810,232
   Common Stock
248
439
448
643
1,910
1,727
2,116
3,859
4,115
4,790
5,851
6,233
6,640
7,058
7,0586,6406,2335,8514,7904,1153,8592,1161,7271,910643448439248
   Retained Earnings -2,404,844-2,109,791-1,400,197-1,059,592-372,533-194,009-120,652-76,240-55,887-43,541-35,200-25,604-12,523-8,410
   Accumulated Other Comprehensive Income 
297
540
1,562
1,969
2,890
5,081
7,884
14,113
35,400
78,971
200,462
465,413
606,971
72,071
72,071606,971465,413200,46278,97135,40014,1137,8845,0812,8901,9691,562540297
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
18,097
39,441
40,245
62,559
99,640
89,836
132,891
516,494
770,366
1,465,789
2,531,392
3,462,775
4,309,880
6,423,222
6,423,2224,309,8803,462,7752,531,3921,465,789770,366516,494132,89189,83699,64062,55940,24539,44118,097



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,226,316
Cost of Revenue-117,835
Gross Profit1,108,4811,108,481
 
Operating Income (+$)
Gross Profit1,108,481
Operating Expense-1,529,119
Operating Income-425,049-420,638
 
Operating Expense (+$)
Research Development859,492
Selling General Administrative507,393
Selling And Marketing Expenses202,146
Operating Expense1,529,1191,569,031
 
Net Interest Income (+$)
Interest Income92,962
Interest Expense-904
Other Finance Cost-0
Net Interest Income92,058
 
Pretax Income (+$)
Operating Income-425,049
Net Interest Income92,058
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-304,496-449,133
EBIT - interestExpense = -332,991
-304,496
-294,149
Interest Expense904
Earnings Before Interest and Taxes (EBIT)-332,087-303,592
Earnings Before Interest and Taxes (EBITDA)-220,780
 
After tax Income (+$)
Income Before Tax-304,496
Tax Provision--9,443
Net Income From Continuing Ops-295,053-295,053
Net Income-295,053
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,646,954
Total Other Income/Expenses Net24,084-92,058
 

Technical Analysis of Argenx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Argenx. The general trend of Argenx is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Argenx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of argenx NV ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 411.23 < 413.10 < 416.91.

The bearish price targets are: 349.86 > 333.07 > 327.73.

Tweet this
argenx NV ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of argenx NV ADR. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

argenx NV ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of argenx NV ADR. The current macd is -5.63779869.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Argenx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Argenx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Argenx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
argenx NV ADR Daily Moving Average Convergence/Divergence (MACD) Chartargenx NV ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of argenx NV ADR. The current adx is 14.29.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Argenx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
argenx NV ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of argenx NV ADR. The current sar is 409.19.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
argenx NV ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of argenx NV ADR. The current rsi is 29.50. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
argenx NV ADR Daily Relative Strength Index (RSI) Chartargenx NV ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of argenx NV ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Argenx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
argenx NV ADR Daily Stochastic Oscillator Chartargenx NV ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of argenx NV ADR. The current cci is -180.81597529.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
argenx NV ADR Daily Commodity Channel Index (CCI) Chartargenx NV ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of argenx NV ADR. The current cmo is -61.89548053.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
argenx NV ADR Daily Chande Momentum Oscillator (CMO) Chartargenx NV ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of argenx NV ADR. The current willr is -99.2353644.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
argenx NV ADR Daily Williams %R Chartargenx NV ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of argenx NV ADR.

argenx NV ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of argenx NV ADR. The current atr is 10.27.

argenx NV ADR Daily Average True Range (ATR) Chartargenx NV ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of argenx NV ADR. The current obv is 1,508,621.

argenx NV ADR Daily On-Balance Volume (OBV) Chartargenx NV ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of argenx NV ADR. The current mfi is 19.68.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
argenx NV ADR Daily Money Flow Index (MFI) Chartargenx NV ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for argenx NV ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

argenx NV ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of argenx NV ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.502
Ma 20Greater thanMa 50386.878
Ma 50Greater thanMa 100388.273
Ma 100Greater thanMa 200398.346
OpenGreater thanClose362.340
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Argenx with someone you think should read this too:
  • Are you bullish or bearish on Argenx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Argenx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about argenx NV ADR

I send you an email if I find something interesting about argenx NV ADR.


Comments

How you think about this?

Leave a comment

Stay informed about argenx NV ADR.

Receive notifications about argenx NV ADR in your mailbox!